Summit Therapeutics与Lunit宣布达成一项合作协议,双方将把人工智能驱动的Scope IO平台引入免疫肿瘤学开发领域,用于肿瘤微环境的深入分析。
Summit Therapeutics与Lunit宣布达成一项合作协议,双方将把人工智能驱动的Scope IO平台引入免疫肿瘤学开发领域,用于肿瘤微环境的深入分析。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.